Cogent Biosciences
COGT
#5784
Rank
โ‚น73.63 B
Marketcap
โ‚น666.59
Share price
0.51%
Change (1 day)
39.63%
Change (1 year)

Cogent Biosciences (COGT) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น28.52 Billion

According to Cogent Biosciences's latest financial reports the company has โ‚น28.52 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cogent Biosciences - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น22.12 B3.1%
2022-12-31โ‚น21.45 B31.21%
2021-12-31โ‚น16.35 B-7.68%
2020-12-31โ‚น17.71 B563.7%
2019-12-31โ‚น2.66 B-51.44%
2018-12-31โ‚น5.49 B110.12%
2017-12-31โ‚น2.61 B-43.82%
2016-12-31โ‚น4.65 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น1.39 B-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น34.55 B 21.13%๐Ÿ‡บ๐Ÿ‡ธ USA